Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Studies of Indole Based Thiadiazole Derivatives as Dual Inhibitor of Acetylcholinesterase and Butyrylchloinesterase

Molecules. 2022 Oct 29;27(21):7368. doi: 10.3390/molecules27217368.

Abstract

The current study was conducted to obtain hybrid analogues of indole-based thiadiazole derivatives (1-16) in which a number of reaction steps were involved. To examine their biological activity in the presence of the reference drug Donepezil (0.21 ± 0.12 and 0.30 ± 0.32 M, respectively), the inhibitory potentials of AChE and BuChE were determined for these compounds. Different substituted derivatives showing a varied range of inhibitory profiles, when compared to the reference drug, analogue 8 was shown to have potent activity, with IC50 values for AchE 0.15 ± 0.050 M and BuChE 0.20 ± 0.10, respectively, while other substituted compounds displayed good to moderate potentials. Varied spectroscopic techniques including 1H, 13CNMR and HREI-MS were used to identify the basic skeleton of these compounds. Furthermore, all analogues have a known structure-activity relationship (SAR), and molecular docking investigations have verified the binding interactions of molecule to the active site of enzymes.

Keywords: AchE and BuChE inhibitors; SAR; indole; molecular docking; thiadiazole analogs.

MeSH terms

  • Acetylcholinesterase* / metabolism
  • Cholinesterase Inhibitors / chemistry
  • Indoles / pharmacology
  • Molecular Docking Simulation
  • Molecular Structure
  • Structure-Activity Relationship
  • Thiadiazoles* / chemistry
  • Thiadiazoles* / pharmacology

Substances

  • Acetylcholinesterase
  • Cholinesterase Inhibitors
  • Thiadiazoles
  • Indoles